Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson's disease.
人类诱导多能干细胞衍生产品用于帕金森病自体细胞治疗的临床前安全性和有效性
期刊:Cell Stem Cell
影响因子:20.4
doi:10.1016/j.stem.2025.01.006
Jeon Jeha, Cha Young, Hong Yean Ju, Lee In-Hee, Jang Heejin, Ko Sanghyeok, Naumenko Serhiy, Kim Minseon, Ryu Hannah L, Shrestha Zenith, Lee Nayeon, Park Tae-Yoon, Park HoeWon, Kim Seo-Hyun, Yoon Ki-Jun, Song Bin, Schweitzer Jeffrey, Herrington Todd M, Kong Sek Won, Carter Bob, Leblanc Pierre, Kim Kwang-Soo
